新時達(002527.SZ):擬於2025年年底之前推出具身智能/人形機器人
格隆匯5月7日丨新時達(002527.SZ)在投資者互動平臺表示,公司的核心是基於算法和軟件的控制技術,基於對“腦”和驅動的理解,公司擬於2025年年底之前推出具身智能/人形機器人。具體進展情況請您關注公司在指定信息披露媒體巨潮資訊網披露的相關公告。公司根據《企業會計準則》和公司會計政策的相關規定,基於謹慎性原則合理計提存貨跌價準備,更加真實、準確地反映公司財務狀況及經營成果。未來,公司會加強市場調研與預測,準確把握市場需求、競爭和行業趨勢,合理安排生產採購;優化供應鏈管理,與供應商靈活合作,平衡存貨供應需求;努力提升項目類業務的週轉效率。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.